title: The malarial parasite Plasmodium falciparum imports the human protein peroxiredoxin 2 for peroxide detoxification.
abstract: Coevolution of the malarial parasite and its human host has resulted in a complex network of interactions contributing to the homeodynamics of the host-parasite unit. As a rapidly growing and multiplying organism, Plasmodium falciparum depends on an adequate antioxidant defense system that is efficient despite the absence of genuine catalase and glutathione peroxidase. Using different experimental approaches, we demonstrate that P. falciparum imports the human redox-active protein peroxiredoxin 2 (hPrx-2, hTPx1) into its cytosol. As shown by confocal microscopy and immunogold electron microscopy, hPrx-2 is also present in the Maurer's clefts, organelles that are described as being involved in parasite protein export. Enzyme kinetic analyses prove that hPrx-2 accepts Plasmodium cytosolic thioredoxin 1 as a reducing substrate. hPrx-2 accounts for roughly 50% of thioredoxin peroxidase activity in parasite extracts, thus indicating a functional role of hPrx-2 as an enzymatic scavenger of peroxides in the parasite. Under chloroquine treatment, a drug promoting oxidative stress, the abundance of hPrx-2 in the parasite increases significantly. P. falciparum has adapted to adopt the hPrx-2, thereby using the host protein for its own purposes.
authors: Interdisciplinary Research Center, Heinrich-Buff-Ring 26-32, D-35392 Giessen, Germany.
authors: Sasa
authors: S
authors: Koncarevic
authors: Petra
authors: P
authors: Rohrbach
authors: Marcel
authors: M
authors: Deponte
authors: Georg
authors: G
authors: Krohne
authors: Judith Helena
authors: JH
authors: Prieto
authors: John
authors: J
authors: Yates
authors: Stefan
authors: S
authors: Rahlfs
authors: Katja
authors: K
authors: Becker
mesh_terms: D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism; D002457:Cell Extracts; D002738:Chloroquine / Q000494:pharmacology; D003600:Cytosol / Q000187:drug effects / Q000648:ultrastructure; D004912:Erythrocytes / Q000166:cytology / Q000187:drug effects / Q000469:parasitology / Q000648:ultrastructure; D005455:Fluorescent Antibody Technique; D049452:Green Fluorescent Proteins / Q000378:metabolism; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D008658:Inactivation, Metabolic; D007700:Kinetics; D016778:Malaria, Falciparum / Q000469:parasitology*; D008565:Membrane Proteins / Q000378:metabolism; D010545:Peroxides / Q000378:metabolism*; D054464:Peroxiredoxins / Q000378:metabolism* / Q000648:ultrastructure; D010963:Plasmodium falciparum / Q000166:cytology / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D021381:Protein Transport / Q000187:drug effects; D015800:Protozoan Proteins / Q000378:metabolism; D014617:Vacuoles / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure
chemical_list: D002352:Carrier Proteins; D002457:Cell Extracts; D006454:Hemoglobins; D008565:Membrane Proteins; D010545:Peroxides; C417763:Pfsbp1 protein, Plasmodium falciparum; D015800:Protozoan Proteins; D049452:Green Fluorescent Proteins; D002738:Chloroquine; C086065:PRDX2 protein, human; D054464:Peroxiredoxins